Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Equity to Asset 0.40
OTCPK:FMCQF's Equity to Asset is ranked lower than
56% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. OTCPK:FMCQF: 0.40 )
Ranked among companies with meaningful Equity to Asset only.
OTCPK:FMCQF' s 10-Year Equity to Asset Range
Min: 0.34  Med: 0.41 Max: 0.5
Current: 0.4
0.34
0.5
Interest Coverage 4.55
OTCPK:FMCQF's Interest Coverage is ranked lower than
61% of the 131 Companies
in the Global Medical Care industry.

( Industry Median: 6.81 vs. OTCPK:FMCQF: 4.55 )
Ranked among companies with meaningful Interest Coverage only.
OTCPK:FMCQF' s 10-Year Interest Coverage Range
Min: 1.6  Med: 4.44 Max: 9999.99
Current: 4.55
1.6
9999.99
F-Score: 6
Z-Score: 2.01
M-Score: -3.30
WACC vs ROIC
1.66%
8.89%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 13.83
OTCPK:FMCQF's Operating margin (%) is ranked higher than
71% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 7.35 vs. OTCPK:FMCQF: 13.83 )
Ranked among companies with meaningful Operating margin (%) only.
OTCPK:FMCQF' s 10-Year Operating margin (%) Range
Min: 7.8  Med: 14.78 Max: 16.26
Current: 13.83
7.8
16.26
Net-margin (%) 6.32
OTCPK:FMCQF's Net-margin (%) is ranked higher than
65% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 3.55 vs. OTCPK:FMCQF: 6.32 )
Ranked among companies with meaningful Net-margin (%) only.
OTCPK:FMCQF' s 10-Year Net-margin (%) Range
Min: -6.47  Med: 6.53 Max: 8.6
Current: 6.32
-6.47
8.6
ROE (%) 11.18
OTCPK:FMCQF's ROE (%) is ranked higher than
59% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 9.02 vs. OTCPK:FMCQF: 11.18 )
Ranked among companies with meaningful ROE (%) only.
OTCPK:FMCQF' s 10-Year ROE (%) Range
Min: -11.76  Med: 11.78 Max: 14.68
Current: 11.18
-11.76
14.68
ROA (%) 4.32
OTCPK:FMCQF's ROA (%) is ranked higher than
55% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 3.66 vs. OTCPK:FMCQF: 4.32 )
Ranked among companies with meaningful ROA (%) only.
OTCPK:FMCQF' s 10-Year ROA (%) Range
Min: -4.47  Med: 4.89 Max: 6.22
Current: 4.32
-4.47
6.22
ROC (Joel Greenblatt) (%) 43.81
OTCPK:FMCQF's ROC (Joel Greenblatt) (%) is ranked higher than
73% of the 218 Companies
in the Global Medical Care industry.

( Industry Median: 16.21 vs. OTCPK:FMCQF: 43.81 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
OTCPK:FMCQF' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -3.05  Med: 43.91 Max: 60.99
Current: 43.81
-3.05
60.99
Revenue Growth (3Y)(%) 9.90
OTCPK:FMCQF's Revenue Growth (3Y)(%) is ranked higher than
66% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. OTCPK:FMCQF: 9.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
OTCPK:FMCQF' s 10-Year Revenue Growth (3Y)(%) Range
Min: -4.6  Med: 6.50 Max: 17.2
Current: 9.9
-4.6
17.2
EBITDA Growth (3Y)(%) 6.70
OTCPK:FMCQF's EBITDA Growth (3Y)(%) is ranked lower than
52% of the 126 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. OTCPK:FMCQF: 6.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
OTCPK:FMCQF' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0  Med: 7.90 Max: 43.1
Current: 6.7
0
43.1
EPS Growth (3Y)(%) 1.60
OTCPK:FMCQF's EPS Growth (3Y)(%) is ranked lower than
64% of the 118 Companies
in the Global Medical Care industry.

( Industry Median: 8.40 vs. OTCPK:FMCQF: 1.60 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
OTCPK:FMCQF' s 10-Year EPS Growth (3Y)(%) Range
Min: -18.1  Med: 13.35 Max: 63.5
Current: 1.6
-18.1
63.5
» OTCPK:FMCQF's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with OTCPK:FMCQF

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Fresenius Medical Care AG & Co. KGaA

SymbolPriceYieldDescription
FMCMF67.800.00
FME3.Germany54.200.96
FMSPR0.001.06ADR

Ratios

vs
industry
vs
history
P/E(ttm) 23.30
FMCQF's P/E(ttm) is ranked higher than
60% of the 148 Companies
in the Global Medical Care industry.

( Industry Median: 27.50 vs. FMCQF: 23.30 )
Ranked among companies with meaningful P/E(ttm) only.
FMCQF' s 10-Year P/E(ttm) Range
Min: 13.32  Med: 20.00 Max: 29.39
Current: 23.3
13.32
29.39
Forward P/E 21.83
FMCQF's Forward P/E is ranked lower than
66% of the 91 Companies
in the Global Medical Care industry.

( Industry Median: 19.23 vs. FMCQF: 21.83 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 23.30
FMCQF's PE(NRI) is ranked higher than
59% of the 148 Companies
in the Global Medical Care industry.

( Industry Median: 28.90 vs. FMCQF: 23.30 )
Ranked among companies with meaningful PE(NRI) only.
FMCQF' s 10-Year PE(NRI) Range
Min: 13.2  Med: 19.98 Max: 29.33
Current: 23.3
13.2
29.33
P/B 2.35
FMCQF's P/B is ranked higher than
57% of the 190 Companies
in the Global Medical Care industry.

( Industry Median: 2.65 vs. FMCQF: 2.35 )
Ranked among companies with meaningful P/B only.
FMCQF' s 10-Year P/B Range
Min: 0.56  Med: 2.40 Max: 3.01
Current: 2.35
0.56
3.01
P/S 1.40
FMCQF's P/S is ranked higher than
52% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 1.55 vs. FMCQF: 1.40 )
Ranked among companies with meaningful P/S only.
FMCQF' s 10-Year P/S Range
Min: 1.03  Med: 1.50 Max: 1.89
Current: 1.4
1.03
1.89
PFCF 20.71
FMCQF's PFCF is ranked higher than
54% of the 113 Companies
in the Global Medical Care industry.

( Industry Median: 22.16 vs. FMCQF: 20.71 )
Ranked among companies with meaningful PFCF only.
FMCQF' s 10-Year PFCF Range
Min: 13.96  Med: 22.93 Max: 54
Current: 20.71
13.96
54
POCF 11.59
FMCQF's POCF is ranked higher than
66% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 14.76 vs. FMCQF: 11.59 )
Ranked among companies with meaningful POCF only.
FMCQF' s 10-Year POCF Range
Min: 9.49  Med: 12.50 Max: 19.47
Current: 11.59
9.49
19.47
EV-to-EBIT 14.21
FMCQF's EV-to-EBIT is ranked higher than
72% of the 166 Companies
in the Global Medical Care industry.

( Industry Median: 20.01 vs. FMCQF: 14.21 )
Ranked among companies with meaningful EV-to-EBIT only.
FMCQF' s 10-Year EV-to-EBIT Range
Min: 7.4  Med: 12.50 Max: 17.6
Current: 14.21
7.4
17.6
PEG 2.77
FMCQF's PEG is ranked higher than
50% of the 68 Companies
in the Global Medical Care industry.

( Industry Median: 2.77 vs. FMCQF: 2.77 )
Ranked among companies with meaningful PEG only.
FMCQF' s 10-Year PEG Range
Min: 0.8  Med: 1.99 Max: 23.04
Current: 2.77
0.8
23.04
Shiller P/E 24.78
FMCQF's Shiller P/E is ranked higher than
63% of the 86 Companies
in the Global Medical Care industry.

( Industry Median: 30.14 vs. FMCQF: 24.78 )
Ranked among companies with meaningful Shiller P/E only.
FMCQF' s 10-Year Shiller P/E Range
Min: 17.38  Med: 24.49 Max: 34.27
Current: 24.78
17.38
34.27
Current Ratio 1.85
FMCQF's Current Ratio is ranked higher than
72% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 1.35 vs. FMCQF: 1.85 )
Ranked among companies with meaningful Current Ratio only.
FMCQF' s 10-Year Current Ratio Range
Min: 0.8  Med: 1.40 Max: 1.93
Current: 1.85
0.8
1.93
Quick Ratio 1.85
FMCQF's Quick Ratio is ranked higher than
74% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 1.25 vs. FMCQF: 1.85 )
Ranked among companies with meaningful Quick Ratio only.
FMCQF' s 10-Year Quick Ratio Range
Min: 0.7  Med: 1.15 Max: 1.85
Current: 1.85
0.7
1.85
Days Inventory 29.54
FMCQF's Days Inventory is ranked lower than
64% of the 156 Companies
in the Global Medical Care industry.

( Industry Median: 17.78 vs. FMCQF: 29.54 )
Ranked among companies with meaningful Days Inventory only.
FMCQF' s 10-Year Days Inventory Range
Min: 28.17  Med: 38.99 Max: 49.64
Current: 29.54
28.17
49.64
Days Sales Outstanding 75.85
FMCQF's Days Sales Outstanding is ranked lower than
83% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 46.02 vs. FMCQF: 75.85 )
Ranked among companies with meaningful Days Sales Outstanding only.
FMCQF' s 10-Year Days Sales Outstanding Range
Min: 4.01  Med: 79.83 Max: 88.77
Current: 75.85
4.01
88.77

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.14
FMCQF's Dividend Yield is ranked lower than
67% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 1.77 vs. FMCQF: 1.14 )
Ranked among companies with meaningful Dividend Yield only.
FMCQF' s 10-Year Dividend Yield Range
Min: 0.94  Med: 1.40 Max: 2.07
Current: 1.14
0.94
2.07
Dividend Payout 0.25
FMCQF's Dividend Payout is ranked higher than
78% of the 134 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. FMCQF: 0.25 )
Ranked among companies with meaningful Dividend Payout only.
FMCQF' s 10-Year Dividend Payout Range
Min: 0.91  Med: 1.10 Max: 1.36
Current: 0.25
0.91
1.36
Dividend growth (3y) 6.30
FMCQF's Dividend growth (3y) is ranked lower than
64% of the 67 Companies
in the Global Medical Care industry.

( Industry Median: 11.90 vs. FMCQF: 6.30 )
Ranked among companies with meaningful Dividend growth (3y) only.
FMCQF' s 10-Year Dividend growth (3y) Range
Min: 0  Med: 0.00 Max: 8
Current: 6.3
0
8
Yield on cost (5-Year) 1.67
FMCQF's Yield on cost (5-Year) is ranked lower than
58% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 2.12 vs. FMCQF: 1.67 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
FMCQF' s 10-Year Yield on cost (5-Year) Range
Min: 1.37  Med: 2.05 Max: 3.03
Current: 1.67
1.37
3.03
Share Buyback Rate 0.20
FMCQF's Share Buyback Rate is ranked higher than
84% of the 124 Companies
in the Global Medical Care industry.

( Industry Median: -2.30 vs. FMCQF: 0.20 )
Ranked among companies with meaningful Share Buyback Rate only.
FMCQF' s 10-Year Share Buyback Rate Range
Min: 0.6  Med: -0.60 Max: -8.7
Current: 0.2

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.23
FMCQF's Price/Projected FCF is ranked higher than
68% of the 99 Companies
in the Global Medical Care industry.

( Industry Median: 1.53 vs. FMCQF: 1.23 )
Ranked among companies with meaningful Price/Projected FCF only.
FMCQF' s 10-Year Price/Projected FCF Range
Min: 0.97  Med: 1.47 Max: 3.18
Current: 1.23
0.97
3.18
Price/DCF (Earnings Based) 1.50
FMCQF's Price/DCF (Earnings Based) is ranked higher than
52% of the 23 Companies
in the Global Medical Care industry.

( Industry Median: 1.50 vs. FMCQF: 1.50 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.00
FMCQF's Price/Median PS Value is ranked higher than
66% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 1.12 vs. FMCQF: 1.00 )
Ranked among companies with meaningful Price/Median PS Value only.
FMCQF' s 10-Year Price/Median PS Value Range
Min: 0.22  Med: 0.99 Max: 1.77
Current: 1
0.22
1.77
Price/Peter Lynch Fair Value 3.88
FMCQF's Price/Peter Lynch Fair Value is ranked lower than
76% of the 51 Companies
in the Global Medical Care industry.

( Industry Median: 2.50 vs. FMCQF: 3.88 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
FMCQF' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.9  Med: 1.99 Max: 4.73
Current: 3.88
0.9
4.73
Earnings Yield (Greenblatt) (%) 7.00
FMCQF's Earnings Yield (Greenblatt) (%) is ranked higher than
78% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 4.20 vs. FMCQF: 7.00 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
FMCQF' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 5.7  Med: 8.00 Max: 13.5
Current: 7
5.7
13.5
Forward Rate of Return (Yacktman) (%) 10.04
FMCQF's Forward Rate of Return (Yacktman) (%) is ranked lower than
55% of the 103 Companies
in the Global Medical Care industry.

( Industry Median: 11.15 vs. FMCQF: 10.04 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
FMCQF' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -8.2  Med: 11.50 Max: 19.8
Current: 10.04
-8.2
19.8

Analyst Estimate

Dec15 Dec16 Dec17
Revenue(Mil) 16,854 18,273 19,425
EPS($) 2.96 3.50 4.54
EPS without NRI($) 2.96 3.50 4.54

Business Description

Industry: Health Care Providers » Medical Care
Compare: » details
Traded in other countries:0H9X.UK, FMS.USA, FMEN.Germany, FME3.Germany, FME.Switzerland, 0EH5.UK, FME N.Mexico, 0QJE.UK, FME.Germany, FMEA.Germany,
Fresenius Medical Care AG & Co. KGaA was incorporated on August 5, 1996. It is a kidney dialysis company, operating in both the field of dialysis products and the field of dialysis services. The Company's dialysis business is vertically integrated, providing dialysis treatment at its own dialysis clinics and supplying these clinics with different products. In addition, to providing dialysis treatments, includes pharmacy services and vascular access surgery services. It sells dialysis products to other dialysis service providers. It also develops and manufactures equipment, systems and disposable products, which it sells to customers in over 120 countries. It offers life-maintaining and life-saving dialysis services and products in a market which is characterized by a favorable demographic development. It provides expanded and enhanced patient services, including renal pharmaceutical products and laboratory services, to both its own clinics and those of third parties. The Company's clinics also provide services for home dialysis patients, the majority of whom receive peritoneal dialysis treatment. It also provides dialysis services under contract to hospitals in the U.S. on an 'as needed' basis for hospitalized ESRD patients and for patients suffering from acute kidney failure. The Company provides laboratory testing and marketing services in the U.S. through Spectra Laboratories (Spectra). Spectra provides blood, urine and other bodily fluid testing services to determine the appropriate individual dialysis therapy for a patient and to assist physicians in determining whether a dialysis patient's therapy regimen, diet and medicines remain optimal. The Company's main trademarks are the name 'Fresenius' and the 'F' logo'. The Company's competitors in the sale of hemodialysis and peritoneal dialysis products include, Baxter International Inc., Asahi Kasei Kuraray Medical Co. Ltd., Bellco S.r.l., B. Braun Melsungen AG, Nipro Corporation Ltd., Nikkiso Co., Ltd., Terumo Corporation, Kawasumi Laboratories Inc., Fuso Pharmaceuticals Industries Ltd., and Toray Industries, Inc. The Company's operations are subject to extensive governmental regulation by virtually every country in which it operates, including the U.S., at the federal, state and local levels.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK